CHICAGO--(BUSINESS WIRE)--Patients with liver diseases will have expanded access to advanced ultrasound imaging and transplant options, thanks to new policy allowing doctors to use contrast-enhanced ...

A recent prospective study published in the Indian Journal of Radiology and Imaging in September 2025 highlights Kupffer cell ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms, changes begin to unfold inside the liver. While hepatic fat accumulation ...

Patients with colorectal cancer (CRC) liver metastases had reduced risk of intrahepatic recurrence when using intraoperative contrast-enhanced ultrasounds. A new study published in Digestive and Liver ...

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...

Hepatocellular carcinoma (HCC) is a primary malignancy of the liver and one of the leading causes of cancer-related deaths worldwide. Early detection and accurate diagnosis are crucial for effective ...

Fatty liver disease is becoming one of the fastest-growing metabolic disorders worldwide, often progressing silently without ...

Histotripsy is a new, FDA-approved, minimally invasive technique that destroys liver tumors using high-frequency ultrasound waves. For some patients with liver cancer, they could be spared invasive ...

Doppler ultrasound has emerged as a cornerstone in the non-invasive assessment and management of liver disease by providing real-time information on vascular flow, resistance and tissue perfusion. Its ...

Fatty liver disease often develops silently, but recognising early symptoms and making lifestyle changes may help reduce the ...

Hepatocellular carcinoma (HCC) is a prominent contributor to cancer-related mortality worldwide. Early detection and diagnosis of liver cancer can significantly improve its prognosis and patient ...